Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting ( =http://www.alexza.com//>http://www....)

(Date:3/17/2010)... and Company (NYSE: LLY ) today issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 14 ... , ... ... ...

(Date:3/17/2010)... ... ... ... SILVER SPRING, Md. , March 17 The U.S. Food and Drug Administration today announced the approval of the Esteem – an implanted ...

(Date:3/17/2010)... Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . , ... , ... ... ...

[0] Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations [0] FDA Approves First Totally Implanted Hearing System [0] Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum

... EXTON, Pa., Feb. 13 ViroPharma Incorporated (Nasdaq: ... trial evaluating maribavir used as prophylaxis against cytomegalovirus (CMV) ... that all patients on study drug are being moved ... made based on the results of the Phase 3 ...

... and REHOVOT Israel, February 12 ,Rosetta Genomics Ltd. ... ever in-vivo,efficacy data for a systemic microRNA-based cancer ... a microRNA that was,found to be over expressed ... reduction of tumor mass. These data are being ...

Other Medicine Technology:ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients 2 ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients 3 ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients 4 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 2 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 3 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 4 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 5

ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

(Date:3/21/2010)... March 21 Congressman Chaka Fattah (D-PA) issues the following statement upon passage tonight by the House of Representatives of historic ... ... ... ... ...

(Date:3/21/2010)... , , ... ... Washington : , ... ... The dramatic expansion ...

(Date:3/21/2010)... Statement by Americans United for Life Action President & CEO Dr. Charmaine Yoest : , ... , ... ... ... "Today, Congress ignored the explicit wishes of the American people ...

(Date:3/21/2010)... WASHINGTON , March 22 Speaker Nancy Pelosi spoke on ... the Senate version of health insurance reform legislation by a vote of 219 to 212. ... to improve the Senate bill, passed by a vote of 220 to 211 and goes ... ... ...

(Date:3/21/2010)... American and white cancer patients are treated at similar, ... Published early online in Cancer , a peer-reviewed ... that where patients receive care may partly explain observed ... study, researchers led by Tracy Onega, PhD, MA, of ... than 200,000 Medicare recipients treated for cancer between 1998 ...

[0] Rep. Fattah Says Healthcare Reform Will Work, But Get Ready for Nonsensical Talk About Repeal [0] Concord Coalition Reacts To Health Care Bill Passage: Cost Control Vigilance is Now Crucial [0] Pro-Life Leader Dr. Charmaine Yoest on House Passage of Health Care Legislation [0] Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans'[0] Racial disparities diminish in specialized cancer centers

... evidence that tiny strands of RNA called microRNAs ... cancers, UC Davis researchers have identified one that helps ... disease process, eventually causing it to become fatal. The ... targeting this cellular function and reducing cancer deaths among ...

... Intelligent Device Management,to Streamline Software Delivery to Support ... REDWOOD CITY, Calif., Nov. 28 /PRNewswire-FirstCall/,-- Covidien Ltd. ... leader in advanced,energy-based surgical systems, and Questra Corporation, ... the global launch of,the Valleylab(TM) Exchange Software Update ...

... Neurobiological,Technologies, Inc (NTI (TM)) (Nasdaq: NTII ... Chief Medical Officer, effective as of,November 26, 2007., ... as Vice President, Clinical,Programs with primary responsibility for ... candidate for acute ischemic stroke that is,currently in ...

... Medical Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... that a total of 47 patients,have now undergone ... Aortic Bioprosthesis at seven investigative sites in Europe,within ... Currently,eight patients have surpassed the two year implant ...

... is the Complete Health Resource for Your Dog, Cat, Horse and Other ... ... Nov. 28 Here is the perfect gift for the pet,owner/animal lover on ... Pet Health on its Web site:, http://www.morrisanimalfoundation.org . For a minimum $100 donation, ...

... /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc.,(TSX: NDQ), a developer ... for the operating room, today announced that Dr. ... the corporate story,technology and highlights, including an update ... Focus on Healthcare Conference. The conference,runs from Tuesday, ...

Other Medicine News:Health News:UC Davis researchers identify a cellular pathway that makes prostate cancer fatal 2 Health News:Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System 2 Health News:Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System 3 Health News:ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis 2 Health News:ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis 3 Health News:ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis 4 Health News:Perfect Holiday Gift Idea for the Pet-Animal Lover - Pet Health Manual Available With Donation to Morris Animal Foundation 2 Health News:Novadaq to present at BMO Healthcare Conference 2

UC Davis researchers identify a cellular pathway that makes prostate cancer fatal Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis Perfect Holiday Gift Idea for the Pet-Animal Lover - Pet Health Manual Available With Donation to Morris Animal Foundation Novadaq to present at BMO Healthcare Conference

This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....

The Bair Hugger Model 505 provides safe, quiet and effective warming to patients around the world....

The control unit manage patient temperatures during long complex surgical procedures to help achieve optimal clinical outcomes....

The control unit circulates temperature-controlled water through disposable gel pads applied directly to the patient's body....

Medicine Products:

Insulated Suction/Coagulation Probe, single-incision Model 505 -Bair Hugger® Temperature Management Unit Kimberly-Clark Patient Warming System - Model 100 Control Unit Kimberly-Clark Patient Warming System - Model 1000 Control Unit

( =http://www.alexza.com//>http://www....)Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting,Health